1 / 18

Clinical Application of HER2-Directed Therapies in Breast Cancer

Clinical Application of HER2-Directed Therapies in Breast Cancer. HERA Results: Adjuvant Trastuzumab (8-Year Follow-up): OS – 2 y vs 1 y. ALTTO Trial: Schema. MARIANNE: Phase 3 Trial in HER2+ Breast Cancer (Locally Recurrent/Progressive Advanced or Metastatic). Abbreviations.

benjamin-gonzales
Download Presentation

Clinical Application of HER2-Directed Therapies in Breast Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Application ofHER2-Directed Therapies in Breast Cancer

  2. HERA Results: Adjuvant Trastuzumab (8-Year Follow-up): OS – 2 y vs 1 y

  3. ALTTO Trial: Schema

  4. MARIANNE: Phase 3 Trial in HER2+ Breast Cancer (Locally Recurrent/Progressive Advanced or Metastatic)

  5. Abbreviations

  6. Abbreviations (cont)

  7. References

  8. References (cont)

  9. References (cont)

  10. References (cont)

More Related